Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04482855 · ClinicalTrials.gov registry record · NA
Low-Level Laser in Head and Neck Chronic Lymphedema
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT04482855 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 25 participants.
The verdict
NCT04482855, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of low-level laser treatment (LLLT) on the severity of lymphedema, symptom burden, functional status, and quality of life in HNC survivors.
Interventions
- DEVICE Low-level laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2021-08-19 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04482855
The ClinicalTrials.gov registry entry for NCT04482855 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Low-level laser is the first listed.
NCT04482855 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04482855 about?
NCT04482855 is a clinical study titled "Low-Level Laser in Head and Neck Chronic Lymphedema". The purpose of this study is to evaluate the effect of low-level laser treatment (LLLT) on the severity of lymphedema, symptom burden, functional status, and quality of life in HNC survivors.
What is the current status of trial NCT04482855?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2021-08-19. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT04482855?
The interventions under investigation include: Low-level laser (DEVICE).
Who is sponsoring clinical trial NCT04482855?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.